HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Walsh Selected Research
R Walsh Research Topics
Disease
5
Neoplasms (Cancer)
01/2017 - 06/2001
3
Infections
06/2009 - 01/2001
2
Colorectal Neoplasms (Colorectal Cancer)
02/2007 - 01/2007
1
Stroke (Strokes)
10/2018
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1
Cardiomyopathies (Cardiomyopathy)
01/2010
1
Neuromyelitis Optica (Devic's Disease)
07/2008
1
Inflammation (Inflammations)
07/2008
1
Tuberculosis (Tuberculoses)
07/2008
1
Acoustic Neuroma (Acoustic Neurinoma)
06/2008
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2005
1
Breast Neoplasms (Breast Cancer)
02/2003
1
Metaplasia
06/2001
1
Chest Pain (Chest Pains)
02/2001
1
Peptic Ulcer (Peptic Ulcers)
01/2001
1
Dyspepsia (Indigestion)
01/2001
Drug/Important Bio-Agent (IBA)
2
Paraffin
IBA
08/2013 - 02/2003
2
Antibodies
IBA
07/2008 - 06/2001
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2017
1
Prostaglandins G
IBA
01/2017
1
Cetuximab (Erbitux)
FDA Link
01/2017
1
beta-Glucans
IBA
01/2017
1
BTH1677
IBA
01/2017
1
Carboplatin (JM8)
FDA Link
Generic
01/2017
1
Immunologic Factors (Immunomodulators)
IBA
01/2017
1
Formaldehyde (Formol)
FDA Link
08/2013
1
Amino Acids
FDA Link
01/2010
1
Myosin Heavy Chains (Myosin Heavy Chain)
IBA
01/2010
1
Transforming Growth Factor beta (TGF-beta)
IBA
06/2009
1
Protein Isoforms (Isoforms)
IBA
06/2009
1
Transcription Factors (Transcription Factor)
IBA
06/2009
1
Alemtuzumab (Campath)
FDA Link
07/2008
1
Autoantibodies
IBA
07/2008
1
Antigens
IBA
07/2008
1
polyglutamine
IBA
01/2005
1
Monoclonal Antibodies
IBA
02/2003
1
Progesterone Receptors (Progesterone Receptor)
IBA
06/2001
1
Sildenafil Citrate (Viagra)
FDA Link
02/2001
1
Urea (Carbamide)
FDA Link
Generic
01/2001
Therapy/Procedure
2
Therapeutics
01/2017 - 01/2001
2
Cystectomy
02/2007 - 01/2007
1
Length of Stay
10/2018
1
Drug Therapy (Chemotherapy)
01/2017
1
Kidney Transplantation
07/2008
1
Conservative Treatment
06/2008